PATENT CLAIM ANALYSIS

Application Number: 15751782
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["544", "280000"]

Abstract:
Disclosed are a compound related to inhibiting the activity of an IRAK4 kinase, a pharmaceutical composition thereof, a use thereof in preparing drugs, a method in which same is used for inhibiting the activity of the IRAK4 kinase and a method in which same is used for treating and/or preventing IRAK4 kinase mediated diseases or conditions in mammals (especially humans). The compound has a structural formula I.

Claim (Index 13):
The method of  claim 12 , wherein the autoimmune disease and the inflammatory disease are selected from the group consisting of rheumatoid arthritis, osteoarthritis, juvenile arthritis, chronic obstructive pulmonary disease, multiple sclerosis, systemic lupus erythematosus, psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and irritable bowel syndrome.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.6087
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15022248', '15799315', '15314938', '14423078', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8420632463253561
- 35 USC 102 Novelty (BERT): 0.5392309030578306
- Combined Prediction Score: 0.8117800119986035
- Mean Citation Score: 378.723926
- Max Citation Score: 398.73517
- Similarity Product: 253.3806865451073

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test